AngioDynamics, Inc. (NASDAQ:ANGO) Files An 8-K Regulation FD Disclosure

18

AngioDynamics, Inc. (NASDAQ:ANGO) Files An 8-K Regulation FD Disclosure
Item 7.01 –Regulation FD Disclosure.

99.1

Presentation, dated July 18, 2017.


ANGIODYNAMICS INC Exhibit
EX-99.1 2 an37286965-ex99_1.htm PRESENTATION DATED JULY 18,…
To view the full exhibit click here

About AngioDynamics, Inc. (NASDAQ:ANGO)

AngioDynamics, Inc. designs, manufactures and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. The Company’s devices are used in minimally invasive, image-guided procedures. The Company offers products within three product groupings: Peripheral Vascular, Vascular Access and Oncology/Surgery. The Company’s Peripheral Vascular products include Fluid Management, Venous, Thrombus Management, as well as other core products. The Company’s BioFlo products incorporate Endexo Technology into the manufacturing and design of its Vascular Access products. Its Oncology/Surgery product offerings include its Microwave Ablation products, Radiofrequency Ablation (RFA) and its NanoKnife product lines.

An ad to help with our costs